How to Read a Peptide COA in the UK — A Field-by-Field Guide

Why the COA Is the Document That Matters

In the research peptide market in the United Kingdom, there is no mandatory pre-market testing regime for grey-market compounds. The Medicines and Healthcare products Regulatory Agency (MHRA) regulates licensed medicinal products, but many research peptides exist outside that licensing framework entirely. That means quality control, if it exists at all, rests entirely on the documentation a supplier chooses to provide.

The Certificate of Analysis — commonly abbreviated as COA — is that documentation. It is a laboratory report stating, for a specific production batch, the identity of the compound and its measured purity. In theory, a COA proves that what is in the vial is what the label claims, at the stated concentration and purity. In practice, the credibility of a COA depends entirely on who produced it and how.

Understanding what a COA should contain, and what it often lacks, is therefore the most practical skill anyone researching peptides in the UK can develop. This guide walks through each field in detail.

Field 1 — Batch Number (Lot Number)

The batch number, also called the lot number, is the unique identifier assigned to a specific production run. It is the crucial link between the analytical test and the physical product. A COA without a batch number is not a batch-specific document — it is a generic quality statement that provides no confirmation of the specific vial you are examining.

When you receive a product, the batch number on the label and the batch number on the COA must match. If they do not — or if either document lacks a batch number — you have no verified connection between the test result and the product in front of you. This is not a technicality; it is the entire basis of COA validity.

Reputable suppliers will provide the COA for the specific batch being shipped. Some will include a QR code or URL that links the vial's label directly to its analytical documentation. If a supplier provides a "sample COA" or a document without a batch number cited, that document does not verify your purchase.

Field 2 — Analytical Method: HPLC

High-Performance Liquid Chromatography (HPLC) is the standard method for determining the purity of a peptide compound. The technique works by pumping a solution of the sample through a column packed with a stationary phase, separating the compound from impurities based on their chemical properties. A detector then measures the relative amounts of each component, and the result is expressed as a percentage purity.

For research-grade peptides, the accepted minimum purity for a credible COA is ≥ 98%. A result below this threshold does not meet the standard that serious researchers or clinicians consider acceptable. Importantly, the COA must state that the method used was HPLC (or a recognised equivalent). A purity percentage without a stated method is not a measurement — it is an assertion.

Some COAs report purity by UV absorbance at a single wavelength without column chromatography. This is not the same as HPLC and is far less reliable. Always check that the methodology is explicitly described as HPLC.

Field 3 — Analytical Method: LC-MS (Identity Confirmation)

Liquid Chromatography–Mass Spectrometry (LC-MS) takes verification a step further than HPLC alone. While HPLC tells you how pure the compound is, LC-MS tells you what the compound actually is by measuring its molecular mass. The instrument separates components chromatographically and then passes them into a mass spectrometer, which measures the mass-to-charge ratio (m/z) of the ions produced.

For a peptide COA to be credible, LC-MS confirmation of identity must be present. The observed molecular weight should match the theoretical molecular weight of the stated compound within accepted tolerance (typically ± 0.5 Da for peptides of this size, though this varies by instrument and method). A significant mass discrepancy indicates either a different compound or a substantial structural modification.

HPLC purity without LC-MS identity is insufficient. A highly pure sample of the wrong compound will pass HPLC with flying colours. Only LC-MS can confirm you have the right molecule.

Field 4 — Laboratory Independence and Accreditation

The analytical laboratory must be entirely independent of the supplier. This means it should have no shared ownership, branding, address, or financial relationship with the company selling the product. A laboratory that is part of, or contracted exclusively to, the supplying organisation cannot provide independent verification — it is testing on behalf of the party with a commercial interest in the result.

In the UK context, look for laboratories holding UKAS accreditation (United Kingdom Accreditation Service) or the equivalent international standard, ISO/IEC 17025. UKAS is the national accreditation body recognised by the UK government. Accreditation to ISO/IEC 17025 demonstrates that the laboratory has demonstrated technical competence and operates a quality management system that meets international standards.

You can verify a laboratory's UKAS accreditation status at the UKAS website (ukas.com), where a public register of accredited laboratories is maintained. If the laboratory listed on the COA does not appear in the register, or does not hold accreditation for the specific testing methods claimed, that is a material concern.

Field 5 — Date of Analysis and Analyst Reference

A credible COA will include the date on which analysis was performed. Peptides can degrade over time, particularly if not stored correctly. A COA dated significantly before your purchase does not confirm the current state of the product. As a guideline, analysis dates older than 12–18 months warrant additional scrutiny, and you may wish to request more recent documentation.

The analyst's name or reference code should also appear on the document. This creates a traceable record. Some laboratory COAs include a digital or wet signature from the responsible analyst or quality officer. The presence of this reference does not guarantee quality on its own, but its absence removes a layer of accountability that credible laboratories maintain as standard practice.

Field 6 — Compound Name, CAS Number, and Molecular Weight

The COA must state the full compound name (not a brand name or abbreviation alone), the Chemical Abstracts Service (CAS) registry number, and the theoretical molecular weight. The CAS number is a globally unique identifier for every chemical compound — it is not subject to branding or naming conventions and allows unambiguous identification regardless of how a supplier chooses to label their product.

The LC-MS result should show an observed molecular weight that corresponds to the theoretical value for the CAS-identified compound. If the theoretical and observed values diverge substantially, this is evidence of a different compound, a structural modification (such as improperly cleaved protecting groups), or significant degradation.

What a COA Cannot Tell You

Even a technically excellent COA has limits. It documents the analytical result for a specific batch at a specific point in time. It does not confirm what happens to the compound after it leaves the laboratory — during shipping, storage, or handling. Peptides are sensitive to heat, light, moisture, and repeated freeze-thaw cycles. A COA showing 99.2% purity at the time of manufacture does not guarantee the same purity upon receipt, particularly if the cold chain has been compromised.

A COA also does not address the legal status of the compound in the UK. The MHRA's position on research peptides is a separate question — addressed in our article on the MHRA framework — and requires its own consideration before any other step.

The MHRA Context

The MHRA operates as the competent authority for medicines regulation in the United Kingdom under the Medicines Act 1968 and the Human Medicines Regulations 2012. Research peptides that make medicinal claims — or that are, in practice, intended for human administration — fall within the scope of these regulations regardless of how they are labelled. The agency has issued warnings about the risks of purchasing unlicensed products online, including peptides.

A COA demonstrates quality — or the absence of it. It does not address legality. Both dimensions require attention before any decision is made, and neither substitutes for a consultation with a licensed healthcare professional who can advise in the context of your individual circumstances.

Summary

Reading a peptide COA is not complicated once you know what to look for. The critical elements are the batch number, HPLC purity (≥ 98%, method stated), LC-MS identity confirmation, and an independent accredited laboratory. Without all four, the document does not provide the verification it appears to offer.

Before any decision about a research peptide in the UK, obtain the batch-specific COA, verify the laboratory's independence and accreditation, and consult a licensed healthcare professional. This sequence is not optional — it is the only credible basis for an informed decision.